Investors Launch Suit Over Reckitt's $1.4B Suboxone Deal
Three Reckitt Benckiser Group PLC shareholders launched a derivative complaint Thursday accusing the pharmaceutical company's executives of allowing the criminal and civil misconduct leading to a $1.4 billion settlement to resolve...To view the full article, register now.
Already a subscriber? Click here to view full article